Skip To Main Content

Autogene cevumeran (iNeST)



Phase II

A Study to Evaluate The Efficacy And Safety Of RO7198457 In Combination With Pembrolizumab Versus Pembrolizumab Alone In Participants With Previously Untreated Advanced Melanoma. (IMCODE001)


Solid Tumor

Phase I

A Study of Autogene Cevumeran (R07198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors